These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 7474945

  • 1. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
    Bani D, Bigazzi M, Masini E, Bani G, Sacchi TB.
    Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR, Mendes-Ribeiro AC, Santoro MM, Mendes MA, da Silva MN, Mann GE, Brunini TM.
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [Abstract] [Full Text] [Related]

  • 3. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
    Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS.
    J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
    [Abstract] [Full Text] [Related]

  • 4. Nitric oxide derived from endothelial cells inhibits Na+/H+ exchange in rabbit platelets activated by thrombin.
    Chen H, Guo ZG.
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):333-7. PubMed ID: 10452119
    [Abstract] [Full Text] [Related]

  • 5. Studies on the importance of the proposed release of nitric oxide from platelets.
    Mollace V, Salvemini D, Vane J.
    Thromb Res; 1991 Dec 01; 64(5):533-42. PubMed ID: 1725563
    [Abstract] [Full Text] [Related]

  • 6. Nitridergic platelet pathway activation by hementerin, a metalloprotease from the leech Haementeria depressa.
    Chudzinski-Tavassi AM, Bermej E, Rosenstein RE, Faria F, Sarmiento MI, Alberto F, Sampaio MU, Lazzari MA.
    Biol Chem; 2003 Sep 01; 384(9):1333-9. PubMed ID: 14515997
    [Abstract] [Full Text] [Related]

  • 7. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 8. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP, Hothersall JS, Noronha-Dutra AA.
    Br J Pharmacol; 1998 May 15; 124(1):141-8. PubMed ID: 9630353
    [Abstract] [Full Text] [Related]

  • 9. Increased nitric oxide production in platelets from severe chronic renal failure patients.
    Siqueira MA, Brunini TM, Pereira NR, Martins MA, Moss MB, Santos SF, Lugon JR, Mendes-Ribeiro AC.
    Can J Physiol Pharmacol; 2011 Feb 15; 89(2):97-102. PubMed ID: 21326340
    [Abstract] [Full Text] [Related]

  • 10. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C, Maiolo A, Tua A, Grignani G.
    Haematologica; 2000 Aug 15; 85(8):820-5. PubMed ID: 10942928
    [Abstract] [Full Text] [Related]

  • 11. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
    Crane MS, Rossi AG, Megson IL.
    Br J Pharmacol; 2005 Mar 15; 144(6):849-59. PubMed ID: 15685209
    [Abstract] [Full Text] [Related]

  • 12. The calcium modulator nifedipine exerts its antiaggregatory property via a nitric oxide mediated process.
    Berkels R, Klaus W, Boller M, Rösen R.
    Thromb Haemost; 1994 Aug 15; 72(2):309-12. PubMed ID: 7831670
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1994 Aug 15; 33(5):957-67. PubMed ID: 7987264
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of nitric oxide synthase activity in human platelets by nitroglycerin and authentic nitric oxide.
    Chen LY, Mehta JL.
    J Investig Med; 1997 Feb 15; 45(2):69-74. PubMed ID: 9084577
    [Abstract] [Full Text] [Related]

  • 15. Nitrovasodilators and cGMP inhibit human platelet activation.
    Doni MG, Alexandre A, Padoin E, Bertoncello S, Deana R.
    Cardioscience; 1991 Sep 15; 2(3):161-5. PubMed ID: 1660321
    [Abstract] [Full Text] [Related]

  • 16. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
    Emerson M, Momi S, Paul W, Alberti PF, Page C, Gresele P.
    Thromb Haemost; 1999 Jun 15; 81(6):961-6. PubMed ID: 10404776
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model.
    Priya N, Singh P, Bhatia S, Medhi B, Prasad AK, Parmar VS, Raj HG.
    J Pharm Pharmacol; 2011 Sep 15; 63(9):1175-85. PubMed ID: 21827490
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK.
    Platelets; 2003 Sep 15; 14(7-8):421-7. PubMed ID: 14713511
    [Abstract] [Full Text] [Related]

  • 19. Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers.
    Albert J, Wall n NH, Li N, Frostell C, Hjemdahl P.
    Clin Sci (Lond); 1999 Sep 15; 97(3):345-53. PubMed ID: 10464060
    [Abstract] [Full Text] [Related]

  • 20. [Effects of neferine on platelet aggregation in rabbits].
    Yu J, Hu WS.
    Yao Xue Xue Bao; 1997 Sep 15; 32(1):1-4. PubMed ID: 11243209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.